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Abstract Trefoil factor family (TFF)-domain peptides 1-3 are 
mucin-associated molecules, largely found in epithelia of gastro-
intestinal tissues. Structurally similar, resistant to enzymatic 
degradation, they are up-regulated around areas of epithelial 
damage such as ulcers. Transgenic expression or exogenous 
peptide ameliorates or prevents gastric mucosal damage due to 
indomethacin and some are rapidly up-regulated after cryogenic 
burns. A role in promoting cell migration is strongly suggested. 
Knockout mice lacking TFF1 or TFF3 show significant 
pathology, with the former developing gastric tumours. A recent 
Conference Philippe Laudat agreed upon a new nomenclature for 
these peptides. 
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1. Introduction 
The finding [1] in 1982 of a peptide abundant in porcine 
pancreatic extracts during insulin preparation, and the con-
temporaneous discovery of a c D N A clone during a search for 
estrogen-induced m R N A s in a breast cancer cell line [2], has 
developed into the burgeoning field of trefoil/P-domain pep-
tide research, the subject of an excellent Philippe Laudat 
Conference1. Rechristened the Trefoil Factor Family (TFF) 
[3] domain peptides, these molecules are small, secreted and 
stable, bear one or more conserved motifs [4], and are very 
abundantly expressed wherever mucin secretion occurs, most 
prominently in the mucin-secreting cells of the gastrointestinal 
mucosa [5]. The T F F domain (Fig. 1) shows a structure 
tightly held together by three pairs of disulfide bonds [6,7]. 
These shuffled modules have been highly conserved during 
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evolution; in Xenopus, peptides as well as mucins are known 
that contain multiple T F F domains [8]. Mammalian trefoil 
factors contain either one or two of these domains, but there 
is some debate on the necessity of dimerisation of the single 
domain peptides for function. These peptides are synthesised 
in mucus-secreting cells, co-packaged with the mucus gran-
ules, and are secreted onto epithelial surfaces together with 
the mucus. It is becoming apparent that T F F s are also a new 
family of neuropeptides. 
2. Different trefoil peptides: new nomenclature 
Early work (reviewed in [9]) described the expression and 
distribution of the molecules. In man there are three known 
trefoil factors (Fig. 2): T F F 1 , a single trefoil peptide origi-
nally found in breast cancer cell lines but produced mainly in 
the stomach (originally called pS2 or breast cancer estrogen-
inducible: BCEI) ; T F F 2 (formerly spasmolytic peptide: SP) 
which is abundant in the stomach and duodenal Brunner 's 
glands; and T F F 3 (previously called intestinal trefoil factor: 
ITF) a further single-domain peptide expressed throughout 
the intestine. For several years after their isolation, no func-
tion was ascribable to these molecules, al though their in-
creased expression in chronic inflammatory bowel disease 
and around experimental and peptic ulcers presaged a role 
in mucosal defence and healing. In experimental gastric dam-
age some are up-regulated very rapidly [10]. However, the 
advent of recombinant peptides [11] has allowed both in vitro 
and in vivo studies. It is clear that all T F F peptides thus far 
tested are motogens; they stimulate epithelial cell migration in 
a variety of test systems. It was reported at the meeting that 
T F F 3 , like hepatocyte growth factor (scatter factor) and 
E G F , both powerful motogens, induces the rapid phospho-
rylation of ß-catenin and the down-regulation of E-cadherin. 
Interestingly, epithelial cells stably transfected with T F F 1 
show strikingly diffuse growth patterns in agarose gels, again 
indicating an action on cell migration. 
3. Trefoil peptides and mucosal damage 
In vivo T F F domain peptides are heavily overexpressed in 
the epithelial cells migrating across the base of gastrointestinal 
ulcers, and when subcutaneously administered, will protect 
against experimentally induced mucosal damage [12]; larger 
doses given orally have the same effect [13]. It would thus 
appear that T F F s have a role in inducing the important phe-
nomenon of restitution, in which gastrointestinal epithelial 
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Fig. 1. Consensus sequence of mammalian Trefoil Factor Family 
domains. A single 'trefoil' motif sequence is shown, with arrange-
ment of disulfide bonds. 
cells are able to rapidly migrate across a denuded surface, 
without dividing, to effect closure. Thus trefoil factors can 
be regarded as a potentially important mucosal defence mech-
anism, already present in the visco-elastic mucus layer over-
lying the epithelium, and rapidly up-regulated after mucosal 
damage. 
How do TFF domain peptides exert this effect? Current 
opinion seems sharply divided. Because of the close associa-
tion with mucus, one suggestion is that these peptides inter-
acted with the mucus, possibly to stabilise the mucus gel by 
binding the long mucus molecules together, either by the oli-
gosaccharide side chains or the core protein at exposed sites; 
damaging substances such as gastric acid would therefore not 
reach the epithelial surface so readily. Indeed, the addition of 
trefoil factors to purified mucin preparations leads to a rapid 
increase in optical density and viscosity (and presumably 
therefore on mucus gel formation) and the combination acts 
synergistically in cell migration assays [13]. However, there is 
also early evidence for receptor activation after trefoil peptide 
application to epithelial cells ; the stimulation of electrogenic 
chloride secretion induced by TFF3 only occurs after applica-
tion to the basolateral surface of human cell lines or rat jeju-
num [14]. TFF3 appears to bind a protein present in mem-
brane preparations of colorectal epithelial cells which is 
accompanied by phosphorylation on tyrosine, and the phos-
phorylation of ß-catenin mentioned above occurs within 10 s 
— redolent of a receptor-mediated response [15]. rTFF3 and 
EGF act synergistically in stimulating cell migration and pre-
venting mucosal damage [16], and of course recent work has 
established a link between ß-catenin and EGFR in EGF-medi-
ated signal transduction. 
Old Locus New Locus Old Peptide 
Name Name Name 
BCEI TFF1 pS2/BCEI/pNR-
pNR-105/Md2 
SML1 TFF2 Spasmolytic 
Polypeptide 
TFF3 ITF/P1.B 
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Thus trefoil factors appear to be motogens; early work 
which suggested an action of TFF2 in stimulating epithelial 
cell proliferation was found to be a conditional response to a 
reducing (glutathione) environment [17]. Although it has been 
suggested that trefoil factors may mediate a reduction in 
apoptosis, mice in which the TFF3 gene has been knocked 
out apparently show more proliferating cells in their colonie 
crypts, despite no change in their crypt height [18]. 
Initial experience with over- or under-expression by trans-
genic and knockout mice reinforced the concept that trefoil 
factors conferred mucosal protection: mice ectopically ex-
pressing hTFFl in the jejunum [19] are resistant to indome-
thacin-induced damage, and mice in which the TFF3 gene has 
been knocked out [18] are very sensitive to dextran sodium 
sulphate-induced colitis, and do not form a migrating tongue 
of epithelium across the surface of ulcers. Neither of these 
mice showed a morphological phenotype nor developed any 
apparent disease. However, when the mTFFl gene was 
knocked out, significant pathology was found [20]. All of 
the mice lost the expression of gastric mucus and developed 
adenomas in the antrum of the stomach, and some of these 
went on to develop frankly invasive carcinomas. Because 
hTFFl expression is lost in some 50% of human gastric car-
cinomas, Lefebvre and colleagues suggest that TFF1 must 
therefore be a candidate tumour suppressor gene in the stom-
ach. The mechanism of this merits further investigation but 
certainly brings these enigmatic peptides sharply into focus. 
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